Dr. Ingi El Sayed MD, MBBCh, MSc, FFICM, FRCPE, FHEA, FASN

I am mostly interested in clinical education, especially simulation-based. I believe that problem-based learning, small group discussion and experiential learning are the solid foundations for safer, more confident medical practitioners. 

I am most interested in clinical nephrology, especially diabetic nephropathy and acute kidney injury. As a critical care nephrologist, I am also very interested in providing excellent care to critically ill patients including applying and studying impact of care on outcomes on severity and recovery of acute kidney injury in the critically ill patients. Aprt from this, I also have a passion and a keen interest on performing invasive procedures.

I am mainly interested in clinical research. My main research area is outcomes in relation to patients with renal diseases, ranging from mortality in acute kidney injury patients including those being cared for on Critical Care Units. I am also keen to analyze the real impact of pre-morbid frailty states on outcomes in renal transplant recipients, as well as critically ill patients. Finally, I am currently trying to evaluate the use of machine learning in predicting outcomes among AKI patients.

"Impact of Renal Transplantation on Functional Status in Tacrolimus Era," Ali H, Soliman K, Daoud A, Fülöp T, Halawa A, Elsayed I. Annals of Medicine. DOI:10.1080/07853890.2021.1962963.

"Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant population," Ali H, Soliman K, Daoud A, Elsayed I, Fülöp T, Sharma A & Halawa A. Renal Failure, 42:1, 489-494. DOI: 10.1080/0886022X.2020.1759636.

"A machine learning approach to develop a prediction score for in-hospital mortality in COVID-19 patients with acute kidney damage," Ali H, Elsayed I. AKI & CRRT San Diego 2023. 

"Outcomes After AKI: Are We Communicating Effectively?" Elsayed I. ASN Kidney Week 2022. 

"The Effect of Dialysis Modality Choice on Cognitive Functions in Patients with ESRD: A Meta-Analysis," Mohamed K, Ali H, Daoud A, Mohamed M, Fulop T, Elsayed I. ASN Kidney Week 2019.

"Safety and Outcomes of Different Induction Therapies among Renal Transplant Patients with Moderate and Severe Frailty ERA-EDTA 2019," Ali H, Daoud A, Elsayed I. Nephrology Dialysis Transplantation, Volume 34, Issue Supplement 1, June 2019. https://doi.org/10.1093/ndt/gfz102.SuO019

"Outcomes of Different Induction Therapies in ABO-Incompatible Renal Transplant Recipients in the Tacrolimus Era," K Soliman, H Ali, A Osman, T Fulop, V Rao, I Elsayed. ASN Kidney Week 2019.

"The Impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the ICU," I Elsayed, N Ward, A Tridente, A Raithatha. Critical Care 2016, 20(Suppl 2): P186, page 78.

"Long-term renal and survival outcomes in AKI patients receiving renal replacement therapy in intensive care," I Elsayed, N Pawley, J Rosser, MJ Heap, GH Mills, A Tridente. AH Raithatha Critical Care 2015, 19 (Suppl 1): P305 (35th ISICEM meeting abstract).

"Long term survival in ESRD patients admitted to intensive care unit in a large teaching hospital," I Elsayed, N Pawley, A Tridente, AH Raithatha, M Wilkie. The 52nd ERA-EDTA Congress, London, United Kingdom, May 2015. https://doi.org/10.1093/ndt/gfv183.50.